What the name refers to
An immune-modulating peptide medicine authorised in some countries and investigated in several immune and infectious-disease settings.
Evidence and regulatory context
Medical use or authorisation exists historically or in limited jurisdictions. Current availability, indications and legal classification must be checked against the regulator for the reader’s location.
Reading product records
For peptide listings, identity, chemical purity, peptide quantity, sterility and endotoxin testing answer different questions. A chromatogram or headline purity figure should not be treated as proof of every one of those properties.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.